Doxorubicin and resveratrol co-delivery nanoparticle to overcome doxorubicin resistance

With the extensive application of doxorubicin (DOX), DOX resistance has become one of the main obstacles to the effective treatment of breast cancer. In this paper, DOX and resveratrol (RES) were co-encapsulated in a modified PLGA nanoparticle (NPS) to overcome the DOX resistance. CLSM results indic...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Sci Rep
Asıl Yazarlar: Zhao, Yuan, Huan, Meng-lei, Liu, Miao, Cheng, Ying, Sun, Yang, Cui, Han, Liu, Dao-zhou, Mei, Qi-bing, Zhou, Si-yuan
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group 2016
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5059704/
https://ncbi.nlm.nih.gov/pubmed/27731405
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep35267
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller